StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.90−0.06 (-3.06%)

Close on Nov 18, 2026Market cap $151.33MP/E –Yield –

NervGen Pharma total assets

Total assets on the balance sheet at the end of each period.

NervGen Pharma's total assets was C$23.21M at Dec 31, 2025. For fiscal 2025 it was C$23.21M, up 19.1% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$23.21M+19.1%
FY2024Dec 31, 2024C$19.49M+47.2%
FY2023Jan 1, 2024C$13.24M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$23.21M–
Q4 FY2024Dec 31, 2024C$19.49M–
Q4 FY2023Jan 1, 2024C$13.24M–

More NervGen Pharma figures

See a number that looks wrong?